Normand Blais

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

Adrianus J. de Langen, Melissa L. Johnson, Julien Mazières et al. · The Lancet · 2023 · 507 citations · Full text

Non-small-cell Lung Cancer, Medicine, Pathology +8

Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age

Lambert Busque, Robert Mio, J Mattioli et al. · Blood · 1996 · 466 citations · Full text

A double many-body expansion of the two lowest-energy potential surfaces and nonadiabatic coupling for H3

A. J. C. Varandas, Franklin B. Brown, C. Alden Mead et al. · The Journal of Chemical Physics · 1987 · 394 citations

Engineering, Computational Chemistry, Chemistry +20

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013

Gilles Pernod, Pierre Albaladejo, Anne Godiér et al. · Archives of cardiovascular diseases · 2013 · 305 citations

Thrombosis, Direct Oral Anticoagulants, Cardiovascular Disease +15

Trajectory-surface-hopping study of Na(3<i>p</i> 2<i>P</i>) +H2 → Na(3<i>s</i> 2<i>S</i>)+H2(<i>v</i>′, <i>j</i>′, θ)

Normand Blais, Donald G. Truhlar · The Journal of Chemical Physics · 1983 · 215 citations

Trajectory-surface-hopping Study, Molecular Kinetics, Engineering +13